QHSLab, Inc. (USAQ) stock
USAQOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.32+0.00 (0.00%)
Close on Oct 19, 2026Market cap $7.38MP/E –Yield –
QHSLab r&d expenses
Research and development expenses are spending on new products and technology.
QHSLab's R&D Expenses for the twelve months ending Jun 30, 2026 was $484.01K, up 14.3% year over year. For fiscal 2025 it was $484.87K, up 64.7% from the year before. The highest annual figure on record is $484.87K in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $484.87K | +64.7% |
| FY2024 | Dec 31, 2024 | $294.48K | +37.6% |
| FY2023 | Dec 31, 2023 | $214.01K | +12.6% |
| FY2022 | Dec 31, 2022 | $190.12K | +109.2% |
| FY2021 | Dec 31, 2021 | $90.87K | -7.5% |
| FY2020 | Dec 31, 2020 | $98.29K | -1.9% |
| FY2019 | Dec 31, 2019 | $100.23K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $114.62K | +2.0% |
| Q1 FY2026 | Mar 31, 2026 | $120.91K | -2.5% |
| Q4 FY2025 | Dec 31, 2025 | $115.71K | +7.6% |
| Q3 FY2025 | Sep 30, 2025 | $132.77K | +67.0% |
| Q2 FY2025 | Jun 30, 2025 | $112.36K | +73.4% |
| Q1 FY2025 | Mar 31, 2025 | $124.03K | +190.9% |
| Q4 FY2024 | Dec 31, 2024 | $107.53K | +141.5% |
| Q3 FY2024 | Sep 30, 2024 | $79.50K | +75.0% |
| Q2 FY2024 | Jun 30, 2024 | $64.81K | +7.1% |
| Q1 FY2024 | Mar 31, 2024 | $42.64K | -32.9% |
| Q4 FY2023 | Dec 31, 2023 | $44.52K | -17.7% |
| Q3 FY2023 | Sep 30, 2023 | $45.42K | -6.2% |
| Q2 FY2023 | Jun 30, 2023 | $60.52K | +3.3% |
| Q1 FY2023 | Mar 31, 2023 | $63.55K | +119.3% |
| Q4 FY2022 | Dec 31, 2022 | $54.12K | +93.5% |
| Q3 FY2022 | Sep 30, 2022 | $48.41K | +146.9% |
| Q2 FY2022 | Jun 30, 2022 | $58.62K | +283.8% |
| Q1 FY2022 | Mar 31, 2022 | $28.98K | +3.4% |
| Q4 FY2021 | Dec 31, 2021 | $27.97K | -7.5% |
| Q3 FY2021 | Sep 30, 2021 | $19.61K | -2.7% |
| Q2 FY2021 | Jun 30, 2021 | $15.27K | -24.9% |
| Q1 FY2021 | Mar 31, 2021 | $28.02K | +1.6% |
| Q4 FY2020 | Dec 31, 2020 | $30.23K | +9.9% |
| Q3 FY2020 | Sep 30, 2020 | $20.15K | -27.5% |
| Q2 FY2020 | Jun 30, 2020 | $20.32K | +24.0% |
| Q1 FY2020 | Mar 31, 2020 | $27.59K | -3.4% |
| Q4 FY2019 | Dec 31, 2019 | $27.51K | – |
| Q3 FY2019 | Sep 30, 2019 | $27.79K | – |
| Q2 FY2019 | Jun 30, 2019 | $16.39K | – |
| Q1 FY2019 | Mar 31, 2019 | $28.55K | – |
See a number that looks wrong?